Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Mattsson

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Annals of Surgical Oncology|May 17, 2018
The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb PerfusionDimitrios Katsarelias, Erik Rådbo, Ilan Ben-Shabat, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 18, 2013
Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: a pilot study in patients with in-transit metastases of malignant melanomaRoger Olofsson, Erika Lindberg, Alex Karlsson-Parra, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 28, 2019
Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trialAnna Corderfeldt, Susanne Nielsen, Dimitrios Katsarelias, et al.
Annals of Surgical Oncology|January 9, 2019
Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant MelanomaValerio Belgrano, Jessica Pettersson, Jonas A Nilsson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 16, 2018
Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignanciesRoger Olofsson Bagge, Per Carlson, Roya Razzazian, et al.
BMC Medical Genetics|December 17, 2008
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19pAnnika Bergman, Frida Abel, Afrouz Behboudi, et al.
Oncoimmunology|December 21, 2020
Presence of tumor-infiltrating CD8<sup>+</sup> T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasisJunko Johansson, Jan Siarov, Roberta Kiffin, et al.
Journal of Visualized Experiments : Jove|February 5, 2015
Isolated hepatic perfusion as a treatment for liver metastases of uveal melanomaIlan Ben-Shabat, Christoffer Hansson, Malin Sternby Eilard, et al.
Acta Oncologica (Stockholm, Sweden)|October 23, 2008
Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005Jan Mattsson, Leif Bergkvist, Avni Abdiu, et al.
BMC Cancer|December 17, 2014
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanomaMaria Eldh, Roger Olofsson Bagge, Cecilia Lässer, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Annals of Surgical Oncology|May 17, 2018
The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb PerfusionDimitrios Katsarelias, Erik Rådbo, Ilan Ben-Shabat, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 18, 2013
Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: a pilot study in patients with in-transit metastases of malignant melanomaRoger Olofsson, Erika Lindberg, Alex Karlsson-Parra, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 28, 2019
Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trialAnna Corderfeldt, Susanne Nielsen, Dimitrios Katsarelias, et al.
Annals of Surgical Oncology|January 9, 2019
Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant MelanomaValerio Belgrano, Jessica Pettersson, Jonas A Nilsson, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 16, 2018
Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignanciesRoger Olofsson Bagge, Per Carlson, Roya Razzazian, et al.
BMC Medical Genetics|December 17, 2008
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19pAnnika Bergman, Frida Abel, Afrouz Behboudi, et al.
Oncoimmunology|December 21, 2020
Presence of tumor-infiltrating CD8<sup>+</sup> T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasisJunko Johansson, Jan Siarov, Roberta Kiffin, et al.
Journal of Visualized Experiments : Jove|February 5, 2015
Isolated hepatic perfusion as a treatment for liver metastases of uveal melanomaIlan Ben-Shabat, Christoffer Hansson, Malin Sternby Eilard, et al.
Acta Oncologica (Stockholm, Sweden)|October 23, 2008
Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005Jan Mattsson, Leif Bergkvist, Avni Abdiu, et al.
BMC Cancer|December 17, 2014
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanomaMaria Eldh, Roger Olofsson Bagge, Cecilia Lässer, et al.
Pageof 4